Mission statement · Company scope
“Our mission is to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the CFTR protein to deliver clinically meaningful benefit to people with CF.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary)
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Plain
- Length
- 32 words · reading grade 19.4
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.77
- Record
- st_07789f5e02386ed7
- Classification confidence
- 0.95
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-02 · sec_sentence · 10-K · accession 0001628280-26-012996
View filing ↗0 to compareCompare